Ibuprofen Versus Mecillinam for Uncomplicated Cystitis

NCT01849926 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 383

Last updated 2017-11-06

No results posted yet for this study

Summary

Although uncomplicated cystitis is considered to be a mild condition and mostly self limiting, most patients who see a doctor will be treated with antibiotics. Antibiotics are known to give a quick relief of symptoms and shorten the course of the condition by a few days. The aim of this study is to evaluate ibuprofen versus mecillinam in the treatment of uncomplicated cystitis in otherwise healthy, non-pregnant women. Our main objective is to see whether symptomatic treatment with ibuprofen is equally efficient as treatment with mecillinam in this group.

Conditions

  • Acute Cystitis (Excl in Pregnancy)

Interventions

DRUG

Ibuprofen

DRUG

Mecillinam

Sponsors & Collaborators

  • University of Bergen

    collaborator OTHER
  • Lund University

    collaborator OTHER
  • University of Copenhagen

    collaborator OTHER
  • University of Oslo

    lead OTHER

Principal Investigators

  • Morten Lindbæk, Professor · University of Oslo, faculty of medicine, institute for health and society, department of general medicine, antibiotic centre of primary care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01849926 on ClinicalTrials.gov